A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

PHASE4CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

August 31, 2007

Conditions
Vascular Dementia
Interventions
DRUG

Cerebrolysin

DRUG

0.9% Saline Solution

Trial Locations (21)

Unknown

Chita State Medical Academy/Regional Psychiatric Hospital No. 2, Chita

Chita State Medical Academy/Veterans Hospital, Chita

Irkutsk State Institute of Postgraduate Education/Regional Clinical Hospital, Irkutsk

Kazan State Medical University/Municipal Clinical Hospital No. 6, Kazan'

Kazan State Medical University/Republican Clinical Hospital, Kazan'

Kursk Medical University/Kursk Regional Clinical Hospital, Kursk

I. M. Sechenov Moscow Medical Academy, Moscow

Mental Health Research Center of RAMS/Psychiatric Clinical Hospital No. 15, Moscow

Mental Health Research Center of RAMS, Moscow

Russian Medical Academy of Postgraduate Education/S. P. Botkin Municipal Clinical Hospital, Moscow

Russian State Medical University/N. I. Pirogov Municipal Clinical Hospital No. 1, Moscow

Scientific Research Institute of Neurology of RAMS, Moscow

Municipal Clinical Hospital No. 5, Nizhny Novgorod

N. A. Semashko Nizhniy Novgorod Regional Clinical Hospital, Nizhny Novgorod

Central Municipal Hospital, Reutov

I. P. Pavlov St. Petersburg State Medical University, Saint Petersburg

S. M. Kirkov Medical Military Academy of the Ministry of Defense of RF, Saint Petersburg

V. M. Bekhterev St. Petersburg Scientific Research Psychoneurological Institute, Saint Petersburg

Saratov Regional Psychiatric Hospital of Snt. Sofia, Saratov

Bashkirian State Medical University/Emergency Medical Care Hospital, Ufa

Yaroslavl State Medical Academy/Yaroslavl Clinical Hospital No. 8, Yaroslavl

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

acromion GmbH

INDUSTRY

collaborator

Geny Research Corp.

UNKNOWN

lead

Ever Neuro Pharma GmbH

INDUSTRY

NCT00947531 - A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia | Biotech Hunter | Biotech Hunter